Company / R&D per Share
Alaunos Therapeutics, Inc. R&D per Share History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.23
FY2025
5-year range
$0.23 / $10.17
FY2021-FY2025
Trend
-97.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.19 in FY2012 to $10.17 in FY2024.
Based on SEC 10-K filings.
0.23 in FY2025 with a 5-year CAGR of +3.8%.
Declined from $1.56 to $0.23 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -0.5%
- 5-Year CAGR
- +3.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 97.8% year-over-year.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2012.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.23 | -97.8% |
| FY2024 | $10.17 | +551.3% |
| FY2023 | $1.56 | +579.6% |
| FY2022 | $0.23 | -6.5% |
| FY2021 | $0.25 | +30.8% |
| FY2020 | $0.19 | -32.9% |
| FY2019 | $0.28 | -74.7% |
| FY2018 | $1.11 | +426.1% |
| FY2013 | $0.21 | +12.7% |
| FY2012 | $0.19 | +98.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026